Net Cash Provided by (Used in) Operating Activities in USD of ARROWHEAD PHARMACEUTICALS, INC. from 2016 to 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
ARROWHEAD PHARMACEUTICALS, INC. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2016 to 2025.
  • ARROWHEAD PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Dec 2024 was -$146M, a 24.1% decline year-over-year.
  • ARROWHEAD PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2025 was $180M.
  • ARROWHEAD PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$463M, a 201% decline from 2023.
  • ARROWHEAD PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$154M, a 13% decline from 2022.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

ARROWHEAD PHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$146M -$28.4M -24.1% 01 Oct 2024 31 Dec 2024 10-Q 10 Feb 2025
Q4 2023 -$118M -$42.3M -56% 01 Oct 2023 31 Dec 2023 10-Q 10 Feb 2025
Q4 2022 -$75.5M -$14.2M -23.2% 01 Oct 2022 31 Dec 2022 10-Q 06 Feb 2024
Q4 2021 -$61.3M -$22.4M -57.5% 01 Oct 2021 31 Dec 2021 10-Q 06 Feb 2023
Q4 2020 -$38.9M -$15.4M -65.4% 01 Oct 2020 31 Dec 2020 10-Q 02 Feb 2022
Q4 2019 -$23.5M -$192M -114% 01 Oct 2019 31 Dec 2019 10-Q 04 Feb 2021
Q4 2018 $168M +$183M 01 Oct 2018 31 Dec 2018 10-Q 05 Feb 2020
Q4 2017 -$14.7M 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019

ARROWHEAD PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 $180M +$642M 01 Oct 2024 30 Sep 2025 10-K 25 Nov 2025
2024 -$463M -$309M -201% 01 Oct 2023 30 Sep 2024 10-K 25 Nov 2025
2023 -$154M -$17.8M -13% 01 Oct 2022 30 Sep 2023 10-K 25 Nov 2025
2022 -$136M -$307M -179% 01 Oct 2021 30 Sep 2022 10-K 26 Nov 2024
2021 $171M +$267M 01 Oct 2020 30 Sep 2021 10-K 29 Nov 2023
2020 -$95.8M -$269M -155% 01 Oct 2019 30 Sep 2020 10-K 28 Nov 2022
2019 $173M +$220M 01 Oct 2018 30 Sep 2019 10-K 22 Nov 2021
2018 -$47.2M -$23.3M -97.3% 01 Oct 2017 30 Sep 2018 10-K 23 Nov 2020
2017 -$23.9M +$40.5M +62.8% 01 Oct 2016 30 Sep 2017 10-K 25 Nov 2019
2016 -$64.4M 01 Oct 2015 30 Sep 2016 10-K 11 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.